Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gorelick

Showing results (211-220 of 222) with videos related to

Pageof 23
Sort By:
Alcoholism, Clinical and Experimental Research|August 29, 2022
Validation of serotonin transporter mRNA as a quantitative biomarker of heavy drinking and its comparison to ethyl glucuronide/ethyl sulfate: A randomized, double-blind, crossover trialJessica Cornell, Andrew Conchas, Xin-Qun Wang, et al.
Biological Psychiatry|August 20, 2018
Decreased Cannabinoid CB<sub>1</sub> Receptors in Male Tobacco Smokers Examined With Positron Emission TomographyJussi Hirvonen, Paolo Zanotti-Fregonara, David A Gorelick, et al.
The American Journal of Drug and Alcohol Abuse|July 30, 2011
CB1 - cannabinoid receptor antagonist effects on cortisol in cannabis-dependent menRobert S Goodwin, Michael H Baumann, David A Gorelick, et al.
Journal of Addictive Diseases|April 19, 2007
Risk of psychoactive substance dependence among substance users in a trauma inpatient populationSilvia S Martins, Marc L Copersino, Carl A Soderstrom, et al.
Journal of Addictive Diseases|June 28, 2007
Sociodemographic characteristics associated with substance use status in a trauma inpatient populationSilvia S Martins, Marc L Copersino, Carl A Soderstrom, et al.
Hepatology (Baltimore, Md.)|February 16, 2020
Estrogen Acts Through Estrogen Receptor 2b to Regulate Hepatobiliary Fate During Vertebrate DevelopmentSaireudee Chaturantabut, Arkadi Shwartz, Maija K Garnaas, et al.
Journal of Clinical Pharmacology|July 2, 2016
Pharmacokinetics and Safety Assessment of l-Tetrahydropalmatine in Cocaine Users: A Randomized, Double-Blind, Placebo-Controlled StudyHazem E Hassan, Deanna Kelly, Moshe Honick, et al.
Journal of Clinical Psychopharmacology|December 31, 2010
Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot studyDeanna L Kelly, David A Gorelick, Robert R Conley, et al.
Gastroenterology|January 15, 2019
Estrogen Activation of G-Protein-Coupled Estrogen Receptor 1 Regulates Phosphoinositide 3-Kinase and mTOR Signaling to Promote Liver Growth in Zebrafish and Proliferation of Human HepatocytesSaireudee Chaturantabut, Arkadi Shwartz, Kimberley J Evason, et al.
Developmental Cell|May 30, 2014
Estrogen defines the dorsal-ventral limit of VEGF regulation to specify the location of the hemogenic endothelial nicheKelli J Carroll, Virginie Esain, Maija K Garnaas, et al.
Pageof 23

Showing results (211-220 of 222) with videos related to

Sort By:
Pageof 23
Alcoholism, Clinical and Experimental Research|August 29, 2022
Validation of serotonin transporter mRNA as a quantitative biomarker of heavy drinking and its comparison to ethyl glucuronide/ethyl sulfate: A randomized, double-blind, crossover trialJessica Cornell, Andrew Conchas, Xin-Qun Wang, et al.
Biological Psychiatry|August 20, 2018
Decreased Cannabinoid CB<sub>1</sub> Receptors in Male Tobacco Smokers Examined With Positron Emission TomographyJussi Hirvonen, Paolo Zanotti-Fregonara, David A Gorelick, et al.
The American Journal of Drug and Alcohol Abuse|July 30, 2011
CB1 - cannabinoid receptor antagonist effects on cortisol in cannabis-dependent menRobert S Goodwin, Michael H Baumann, David A Gorelick, et al.
Journal of Addictive Diseases|April 19, 2007
Risk of psychoactive substance dependence among substance users in a trauma inpatient populationSilvia S Martins, Marc L Copersino, Carl A Soderstrom, et al.
Journal of Addictive Diseases|June 28, 2007
Sociodemographic characteristics associated with substance use status in a trauma inpatient populationSilvia S Martins, Marc L Copersino, Carl A Soderstrom, et al.
Hepatology (Baltimore, Md.)|February 16, 2020
Estrogen Acts Through Estrogen Receptor 2b to Regulate Hepatobiliary Fate During Vertebrate DevelopmentSaireudee Chaturantabut, Arkadi Shwartz, Maija K Garnaas, et al.
Journal of Clinical Pharmacology|July 2, 2016
Pharmacokinetics and Safety Assessment of l-Tetrahydropalmatine in Cocaine Users: A Randomized, Double-Blind, Placebo-Controlled StudyHazem E Hassan, Deanna Kelly, Moshe Honick, et al.
Journal of Clinical Psychopharmacology|December 31, 2010
Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot studyDeanna L Kelly, David A Gorelick, Robert R Conley, et al.
Gastroenterology|January 15, 2019
Estrogen Activation of G-Protein-Coupled Estrogen Receptor 1 Regulates Phosphoinositide 3-Kinase and mTOR Signaling to Promote Liver Growth in Zebrafish and Proliferation of Human HepatocytesSaireudee Chaturantabut, Arkadi Shwartz, Kimberley J Evason, et al.
Developmental Cell|May 30, 2014
Estrogen defines the dorsal-ventral limit of VEGF regulation to specify the location of the hemogenic endothelial nicheKelli J Carroll, Virginie Esain, Maija K Garnaas, et al.
Pageof 23